HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurizio Bonfichi Selected Research

Castleman Disease (Castleman's Disease)

10/2018Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurizio Bonfichi Research Topics

Disease

8Hodgkin Disease (Hodgkin's Disease)
10/2021 - 01/2016
3Lymphoma (Lymphomas)
03/2013 - 04/2008
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2015 - 01/2005
2Hypoxia (Hypoxemia)
03/2003 - 01/2003
1Castleman Disease (Castleman's Disease)
10/2018
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2017
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
08/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2014
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2013
1Monoclonal Gammopathy of Undetermined Significance
03/2013
1Proteinuria
03/2013
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2012
1Neutropenia
05/2008
1Multiple Myeloma
05/2008
1Back Pain (Backache)
05/2008
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2008
1Acute Promyelocytic Leukemia
07/2007
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2005
1Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2004
1Primary Myelofibrosis (Myelosclerosis)
09/2004
1Thrombosis (Thrombus)
01/2003

Drug/Important Bio-Agent (IBA)

3Brentuximab VedotinIBA
10/2020 - 10/2017
3Rituximab (Mabthera)FDA Link
08/2015 - 01/2005
2Bendamustine HydrochlorideFDA Link
01/2016 - 08/2015
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2011 - 05/2008
2Proteins (Proteins, Gene)FDA Link
04/2008 - 03/2003
1siltuximabIBA
10/2018
1Bortezomib (Velcade)FDA Link
10/2016
1Vinblastine (Vinblastine Sulfate)FDA Link
04/2016
1Dacarbazine (DIC)FDA LinkGeneric
04/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2016
1IfosfamideFDA LinkGeneric
04/2016
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2016
1GemcitabineFDA Link
01/2016
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2016
1AnthracyclinesIBA
03/2015
1Viral RNAIBA
03/2014
1AlbuminsIBA
03/2014
1Immunoglobulin M (IgM)IBA
03/2013
1Lenalidomide (CC 5013)FDA Link
03/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2012
1Biomarkers (Surrogate Marker)IBA
03/2012
1plerixaforFDA Link
06/2011
1Filgrastim (Neupogen)FDA Link
05/2008
1Analgesics (Analgesic Drugs)IBA
05/2008
1Monoclonal AntibodiesIBA
04/2008
1Indicators and Reagents (Reagents)IBA
04/2008
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2007
1Vincristine (Oncovin)FDA LinkGeneric
01/2005
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2005
1Messenger RNA (mRNA)IBA
09/2004
1Oxygen (Dioxygen)IBA
03/2003
1human VEGFA proteinIBA
03/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2003
1CobaltIBA
01/2003
1Dihydrotachysterol (AT 10)IBA
01/2003

Therapy/Procedure

6Therapeutics
10/2021 - 07/2007
6Drug Therapy (Chemotherapy)
10/2016 - 04/2008
5Stem Cell Transplantation
01/2020 - 03/2015
2Induction Chemotherapy
01/2020 - 01/2016
2Salvage Therapy
04/2016 - 03/2012
1Autologous Transplantation
04/2016
1Hematopoietic Stem Cell Mobilization
05/2008
1Combination Drug Therapy (Combination Chemotherapy)
01/2005
1Immunotherapy
01/2005